Jennifer L. Hay, PhD

Lab Director

Share
Print
Share
Print
Jennifer Hay

Office Phone

646-888-0039

Dr. Jennifer Hay is an Attending Psychologist and Director, Genomics, Risk, and Health Decision-Making Laboratory, as well as Deputy Director of Research Training, within the  Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center (MSK), New York City, New York, USA. Her work focuses on optimizing the public health benefit of novel basic science, genomics, and epidemiological findings in cancer through research concerning cancer risk perceptions and health decision-making, especially in skin cancer prevention. Dr. Hay has been investigating these topics in NIH-funded research, including a recently completed randomized controlled trial examining skin cancer Dr. Jennifer Hay is an Attending Psychologist and Director, Genomics, Risk, and Health Decision-Making Laboratory, as well as Deputy Director of Research Training, within the Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center (MSK), New York City, New York, USA. Her work focuses on optimizing the public health benefit of novel basic science, genomics, and epidemiological findings in cancer through research concerning cancer risk perceptions and health decision-making, especially in skin cancer prevention. Dr. Hay has been investigating these topics in NIH-funded research, including a recently completed randomized controlled trial examining skin cancer genetic testing via MC1R in Albuquerque primary care. She currently co-leads an ongoing study examining solutions to resolving uncertainty about cancer risk. She serves as the behavioral science/psychiatry liaison to the MSK Melanoma Disease Management Team, and in this capacity she provides clinical services to melanoma patients across the treatment trajectory to address distress, decision making, and coping with toxicities, and conducts research examining melanoma prevention as well as patient perspectives regarding treatment decisions and quality of life. Outside of the lab, Dr. Hay enjoys spending time in nature, either hiking or biking.genetic testing via MC1R in Albuquerque primary care. She currently co-leads an ongoing study examining solutions to resolving uncertainty about cancer risk. She serves as the behavioral science/psychiatry liaison to the MSK Melanoma Disease Management Team, and in this capacity she provides clinical services to melanoma patients across the treatment trajectory to address distress, decision making, and coping with toxicities, and conducts research examining melanoma prevention as well as patient perspectives regarding treatment decisions and quality of life. Outside of the lab, Dr. Hay enjoys spending time in nature, either hiking or biking.

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Jennifer L. Hay discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures